Wearable devices that are being trialled by Parkinson’s UK to improve symptom management for sufferers have been granted an EU patent, signalling a green light for the devices to enter the European market in the near future.
The Global Kinetics Corporation’s (GCK) KinetiGraph device, worn on the wrist, records patients’ movements and medication to assess dosage levels and their effectiveness. Charity Parkinson’s UK announced in Autumn 2014 that it would trial the wearables on hundreds of patients over the next 12 months.
Source: Techworld